CHRU de Tours, Clinique Psychiatrique Universitaire, 2 Boulevard Tonnellé, 37042 Tours Cedex 9, France.
CHRU de Tours, Clinique Psychiatrique Universitaire, 2 Boulevard Tonnellé, 37042 Tours Cedex 9, France; CHRU de Tours, Équipe de Liaison et de Soins en Addictologie, 2 Boulevard Tonnellé, 37042 Tours Cedex 9, France; Université François Rabelais de Tours, Département de Psychologie, EA 2114 « Psychologie des Âges de la Vie », 3 rue des Tanneurs BP 4103, 37041 Tours Cedex 1, France.
Psychiatry Res. 2016 Feb 28;236:64-70. doi: 10.1016/j.psychres.2015.12.032. Epub 2015 Dec 25.
This study aimed to determine whether personality disorders were associated with later Major Depressive Disorder (MDD) or Generalised Anxiety Disorder (GAD) in breast cancer patients. This longitudinal and multicentric study included 120 French non-metastatic breast cancer patients. After cancer diagnosis (T1) and 7 months after diagnosis (T3), we assessed MDD and GAD (Mini International Neuropsychiatric Interview 5.0). We assessed personality disorders 3 months after diagnosis (VKP). We used multiple logistic regression analysis to determine what were the factors associated with GAD and MDD at T3. At T3, prevalence rate was 10.8% for MDD and 19.2% for GAD. GAD at T3 was significantly and independently associated with GAD at T1 and with existence of a personality disorder, no matter the cluster type. MDD at T3 was significantly and independently associated with MDD at T1 and with the existence of a cluster C personality disorder. Initial cancer severity and the type of treatment used were not associated with GAD or MDD at T3. Breast cancer patients with personality disorders are at higher risk for GAD and MDD at the end of treatment. Patients with GAD should be screened for personality disorders. Specific interventions for patients with personality disorders could prevent psychiatric disorders.
本研究旨在确定人格障碍是否与乳腺癌患者后期的重度抑郁症(MDD)或广泛性焦虑症(GAD)有关。这项纵向多中心研究纳入了 120 名法国非转移性乳腺癌患者。在癌症诊断后(T1)和诊断后 7 个月(T3),我们评估了 MDD 和 GAD(MINI 国际神经精神访谈 5.0)。我们在诊断后 3 个月(VKP)评估人格障碍。我们使用多变量逻辑回归分析来确定 T3 时与 GAD 和 MDD 相关的因素。在 T3 时,MDD 的患病率为 10.8%,GAD 的患病率为 19.2%。T3 时的 GAD 与 T1 时的 GAD 显著且独立相关,与人格障碍的存在有关,无论集群类型如何。T3 时的 MDD 与 T1 时的 MDD 显著且独立相关,与 C 型人格障碍的存在有关。初始癌症严重程度和使用的治疗类型与 T3 时的 GAD 或 MDD 无关。患有人格障碍的乳腺癌患者在治疗结束时更有可能患 GAD 和 MDD。患有 GAD 的患者应进行人格障碍筛查。针对人格障碍患者的特定干预措施可以预防精神障碍。